Nature predicts China's scientific rise will reshape innovation and the global balance of power.
Nature says China is on a trajectory to lead the world in science. In a feature shared on October 14, 2026, it argues that this rise will reshape technological advancement, innovation and the balance of global power.
99.6K
1 Source, first seen ago
Nature's October 14 feature traces China's scientific rise from a marginal presence in international research to a system that now competes with the world's established leaders. The article says decades of coordinated investment have expanded the country's research output, patent activity and capacity in fields including artificial intelligence, semiconductors, biotechnology and space.
The change is dramatic by one historical measure. In 1978, researchers in China published fewer than 120 papers in international journals, about 0.02% of the global total, according to Scopus data cited by Nature. China is now one of the largest research-and-development spenders, and its universities and institutes have reached the top of Nature Index rankings.
The push remains a national priority. At a meeting in Shanghai in April, President Xi Jinping urged regional governments, universities and research institutes to strengthen fundamental research. China's latest five-year plan also calls for investment in basic science and for faster development of AI, quantum applications and controlled nuclear fusion by the end of the decade.
—
Not ranked yet
—
Not ranked yet
Nature reports that China passed the United States in total public and private R&D spending in 2024 when the figures are adjusted for purchasing power parity, which reflects differences in local costs. The comparison changes under market exchange rates: by that measure, China's spending was about half the US total in 2024.
That distinction matters because no single ranking captures the full state of a national research system. The clearer trend is rapid, sustained growth. China has set a target of increasing overall R&D expenditure by at least 7% annually through 2030.
Long-term industrial policy is part of that effort. A state-backed semiconductor fund launched with roughly 100 billion yuan in 2014. Its third round, launched in 2024, is expected to distribute 344 billion yuan, or roughly $50 billion, as China builds capabilities across chip design, manufacturing and production equipment.
Nature also points to DeepSeek's large language models and China's Tiangong space station as signs of growing confidence in strategically important technologies. These are examples of broader capacity, not proof that China leads every field.
China became the top-ranked country or territory for papers published in the 178 journals tracked by Nature Index after surpassing the United States in 2023. That is a narrow but influential measure of output, and it does not by itself show the originality, quality or practical impact of the work.
Basic research remains a relative weakness. Calculations cited by Nature put fundamental research at just under 7% of China's total R&D budget in 2024, compared with 14.4% in the United States, 11.6% in Japan and 14.7% in South Korea. China's share rose to a record 7.08% in 2025, but it still missed the 8% goal in the five-year plan that ended that year.
Researchers interviewed by Nature also described academic incentives that reward publication volume and grant success, making long, uncertain projects harder to pursue. Research integrity is another concern. A Nature investigation found that nearly 60% of papers retracted between 2014 and 2024 included at least one author affiliated with an institution in China. That statistic describes the affiliations found among retractions, not the share of research from China that is unreliable.
The feature presents scientific investment as both an economic strategy and a response to technological vulnerability. Pandemic-era disruptions and US semiconductor restrictions highlighted the risks of relying on foreign expertise and equipment, while advances in AI, chips and space have become tied to national security and industrial competition.
China has said it wants to expand its global impact in fundamental research by 2035 and become a major international science and innovation center by mid-century. Whether the current trajectory reaches those goals will depend on more than spending and publication counts. Nature identifies misconduct, biomedical-research ethics, a slowing economy and geopolitical tension as possible brakes on progress.
The result is a more complicated picture than a simple change at the top of a league table. China has built the scale, institutions and long-term policy support to alter global research. Its next challenge is converting that scale into durable basic science and trusted breakthroughs.
